UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000038827 |
|---|---|
| Receipt number | R000043795 |
| Scientific Title | Bavencio Intravenous 200 mg Special Drug Use - results Survey (Curatively unresectable Merkel cell carcinoma) |
| Date of disclosure of the study information | 2019/12/10 |
| Last modified on | 2024/02/19 10:10:51 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2019/12/09 15:20:43 | ||
| 2 | Update | 2020/02/13 11:58:50 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information |
|
| 3 | Update | 2020/02/13 17:17:45 | Email |
|
| 4 | Update | 2020/09/15 09:00:54 | Last name of contact person Last name of contact person TEL Name of person sending information Name of person sending information TEL Tel |
|
| 5 | Update | 2022/12/19 14:52:10 | Key inclusion criteria |
|
| 6 | Update | 2022/12/19 14:53:13 | Recruitment status Last follow-up date |
|
| 7 | Update | 2022/12/19 14:54:10 | Key inclusion criteria |
|
| 8 | Update | 2022/12/19 14:57:21 | Recruitment status |
|
| 9 | Update | 2023/06/12 15:33:24 | Recruitment status |
|
| 10 | Update | 2023/06/12 15:37:35 | Number of participants that the trial has enrolled |
|
| 11 | Update | 2024/02/19 10:10:51 | Last name of contact person Last name of contact person TEL Name of person sending information Name of person sending information TEL Tel |
